The Supreme Court refused to quash criminal proceedings against a pharma company accused of manufacturing cough syrup allegedly linked to the death of 18 children in Uzbekistan. The Bench said the incident has “dented” India’s global image and raised serious concerns over drug quality.
The Allahabad High Court overturned the cancellation of Marion Biotech’s drug manufacturing licence following 15 child deaths in Uzbekistan. It criticized Indian authorities for relying on a foreign court’s judgment and emphasized the need for domestic legal procedures. This ruling highlights procedural concerns and may influence future regulatory actions regarding Indian companies abroad.